Client News

Formycon Receives Positive CHMP Opinion for FYB203 (Aflibercept), a Biosimilar Candidate to Eylea® under the Tradenames AHZANTIVE® and Baiama®

InflaRx Receives Positive CHMP Opinion for GOHIBIC® (Vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome

Abivax Presents Third Quarter 2024 Key Financial Information

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

Andera Partners Continues its International Expansion and Announces the Opening of a Madrid Office

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets

Medigene AG Presents Data on an Innovative IFN-γ Biosensor Technology at SITC 2024

Formycon Extends Management Board Contract for CEO Dr. Stefan Glombitza until 2027 and Receives Admission to Trading in the Prime Standard

Medigene AG Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024

Medigene AG Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024